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   2	  
During	  myelination,	   individual	  oligodendrocytes	   initially	  over-­‐produce	  short	  myelin	  sheaths	  that	  are	  20	  
either	  retracted	  or	  stabilised.	  By	  live	  imaging	  oligodendrocyte	  Ca2+	  activity	  in	  vivo,	  we	  find	  that	  high-­‐21	  
amplitude	   long-­‐duration	   Ca2+	   transients	   in	   sheaths	   prefigure	   retractions,	   mediated	   by	   calpain.	  22	  
Following	   stabilisation,	   myelin	   sheaths	   grow	   along	   axons,	   and	   we	   find	   that	   higher	   frequency	   Ca2+	  23	  
transient	   activity	   in	   sheaths	   precedes	   faster	   elongation.	   Our	   data	   implicate	   local	   Ca2+	   signalling	   in	  24	  
regulating	  distinct	  stages	  of	  myelination.	  25	  
	  26	  
	  27	  
Dynamic	  regulation	  of	  myelination	  by	  oligodendrocytes	  in	  the	  central	  nervous	  system	  (CNS)	  is	  essential	  28	  
for	   nervous	   system	   development	   and	   life-­‐long	   function1,	   but	   our	   understanding	   of	   myelin	   sheath	  29	  
formation	  and	  growth	  is	  limited.	  Zebrafish	  are	  well	  suited	  to	  studying	  the	  dynamics	  of	  CNS	  myelination	  30	  
in	   vivo,	   due	   to	   their	   capacity	   for	   non-­‐invasive	   longitudinal	   imaging.	   Previous	   imaging	   studies	   using	  31	  
zebrafish	   have	   shown	   that	   individual	   oligodendrocytes	   initiate	   formation	   and	   elongation	   of	   their	  32	  
myelin	   sheaths	   within	   a	   critical	   period	   of	   about	   5	   hours2,3,	   mirroring	   hours-­‐long	   myelin	   sheath	  33	  
generation	   by	   mammalian	   oligodendrocytes	   in	   vitro4.	   During	   sheath	   formation,	   myelinating	  34	  
oligodendrocytes	  initially	  overproduce	  short	  myelin	  sheaths	  (circa	  5µm	  in	  length),	  with	  some	  stabilised,	  35	  
and	   others	   fully	   retracted2,3,5,6.	   Following	   stabilisation,	   myelin	   sheaths	   grow	   along	   and	   around	  36	  
associated	   axons3,	   to	   achieve	  dimensions	   that	  mediate	   the	   timing	  of	   impulse	   conduction	   and	   thus	  37	  
neural	  circuit	  function7.	  Although	  axonal	  signals,	  including	  neuronal	  activity,	  can	  regulate	  the	  formation	  38	  
and	  growth	  of	  myelin	  sheaths	  (e.g.5,8-­‐10),	  the	  localised	  signalling	  mechanisms	  that	  control	  the	  dynamics	  39	  
of	  myelination	  by	  oligodendrocytes	  remain	  to	  be	  elucidated.	  40	  
Ca2+	  is	  a	  second	  messenger	  that	  regualtes	  many	  events,	  and	  localised	  Ca2+	  activity	  has	  been	  observed	  41	  
in	   oligodendrocyte	   precursor	   cells11,	   myelinating	   oligodendrocytes10,	   and	   even	   in	   mature	   myelin	  42	  
sheaths12	  in	  vitro	  and	  ex	  vivo.	  We	  reasoned	  that	  determining	  how	  localised	  Ca2+	  activity	  relates	  to	  the	  43	  
formation	  and	  growth	  of	  myelin	  sheaths	  in	  vivo	  would	  provide	  novel	  insights	  into	  mechanisms	  of	  CNS	  44	  
myelination.	  	  	  45	  
	  46	  
	  47	  
To	  visualise	  Ca2+	  activity	   in	  myelinating	  oligodendrocytes,	  we	  used	  the	  genetically	  encoded	  calcium	  48	  
indicator	   GCaMP6s13,	   which	   we	   expressed	   in	   oligodendrocytes	   by	   crossing	   Tg(sox10:KalTA4)	   and	  49	  
Tg(uas:GCaMP6s)	   transgenic	   zebrafish	   lines	   (Online	   Methods).	   We	   imaged	   GCaMP6s	   expressing	  50	  
oligodendrocytes	   in	   the	  spinal	   cord	  of	   zebrafish	   larvae	  between	  3-­‐4	  days	  post	   fertilisation	   (dpf),	  as	  51	  
myelin	  sheaths	  are	  being	  formed	  and	  starting	  to	  elongate2,3.	  We	  first	  assessed	  the	  kinetics	  of	  individual	  52	  
	   3	  
localised	  Ca2+	  transients	  in	  myelin	  sheaths	  by	  high-­‐speed	  2D	  (4Hz)	  imaging,	  and	  found	  that	  essentially	  53	  
all	   transients	   lasted	   longer	   than	   3.5	   seconds	   (Supplementary	   Fig.	   1,	   Supplementary	   Movie	   1).	  54	  
Therefore,	  we	  3D	  imaged	  Ca2+	  activity	  in	  all	  myelin	  sheaths	  belonging	  to	  individual	  oligodendrocytes	  55	  
with	   a	   time	   interval	   of	   2.5	   seconds	   (Fig.	   1A-­‐E,	   Online	   Methods,	   Supplementary	   Fig.	   2,	   and	  56	  
Supplementary	  Movies	  2	  and	  3).	  	  57	  
	  58	  
To	   correlate	   Ca2+	   activity	   with	   myelination,	   we	   time-­‐lapse	   imaged	   individual	   GCaMP6s-­‐expressing	  59	  
oligodendrocytes	   for	  multiple	  20	  minute	  blocks	  over	  a	  5-­‐9	  hour	  period	  during	  which	   they	   initiated	  60	  
formation	  and	  elongation	  of	   their	  myelin	   sheaths	   (Fig.	  1F,G).	   	  Prior	   to	  each	  Ca2+	   imaging	  block,	  we	  61	  
acquired	   a	   high-­‐resolution	   3D	   z-­‐stack	   of	   GCaMP6s-­‐expressing	   oligodendrocytes	   together	   with	  62	  
sox10:mRFP,	  which	  allowed	  assessment	  of	  sheath	  morphology	  (Fig.	  1F,G	  and	  see	  Online	  Methods).	  We	  63	  
quantified	  the	  Ca2+	  activity	  of	  305	  sheaths	  of	  18	  oligodendrocytes	  in	  18	  animals.	  Analyses	  of	  448	  Ca2+	  64	  
transients	  in	  the	  187	  sheaths	  that	  exhibited	  activity	  (out	  of	  the	  305	  sheaths	  imaged)	  revealed	  significant	  65	  
diversity	   in	  the	  frequency	  (Fig.1H),	  amplitude	  and	  duration	  of	  transients	  between	  sheaths	  (Fig.	  1I,J)	  66	  
(Median	   amplitude	   per	   sheath	   ∆F/F0=	   0.7,	   IQR=0.9;	  Median	   Ca2+	   transient	   duration=	   23s,	   IQR=17	  67	  
seconds	  per	  sheath).	  We	  also	  found	  that	  duration	  and	  amplitude	  were	  positively	  correlated,	  whereby	  68	  
longer	  duration	  transients	  tended	  to	  also	  be	  of	  higher	  amplitude	  (Fig.	  1K).	  	  69	  
	  70	  
The	  diversity	  in	  Ca2+	  transient	  activity	  between	  sheaths	  suggested	  that	  their	  frequency,	  duration	  and/or	  71	  
amplitude	  may	  influence	  myelination.	  We	  first	  focussed	  on	  the	  relationship	  between	  Ca2+	  activity	  and	  72	  
myelin	  sheath	  formation.	  We	  found	  that	  61	  of	  the	  305	  sheaths	  analysed	  were	  completely	  retracted	  73	  
during	  our	  imaging	  protocol,	  reflecting	  the	  initial	  over-­‐production	  of	  sheaths.	  Intriguingly,	  we	  found	  74	  
that	  the	  amplitude	  of	  Ca2+	  transients	  in	  sheaths	  that	  were	  subsequently	  retracted	  was	  three-­‐fold	  higher	  75	  
than	  in	  those	  sheaths	  that	  were	  stabilised	  (Fig.	  2A,B,D:	  Median	  amplitude	  =1.8	  ∆F/F0	  in	  fully	  retracted	  76	  
sheaths	  vs	  0.6	  ∆F/F0	   in	  stabilised	  sheaths).	  Furthermore,	  we	  observed	  an	   increase	   in	  Ca2+	  transient	  77	  
duration	   in	   sheaths	   that	  were	  subsequently	   retracted	   (Fig.2C,D:	  Median	  duration=	  35s	   in	   retracted	  78	  
sheaths	   vs	   22s	   in	   stabilised).	   Interestingly,	   the	   Ca2+	   transients	   observed	   in	   sheaths	   that	   were	  79	  
subsequently	  retracted	  travelled	  from	  sheath	  to	  process	  (Supplementary	  Fig.	  3,	  Supplementary	  Movie	  80	  
4),	   reflecting	   the	   directionality	   of	   retraction,	   first	   of	   the	   sheath	   and	   then	   the	   process	   (Fig.	   2A,	  81	  
Supplementary	  Fig.	  4).	  These	  observations	  lead	  us	  to	  hypothesise	  that	  localised	  high-­‐amplitude	  long-­‐82	  
duration	   Ca2+	   transients	   may	   mediate	   sheath	   retraction	   through	   activation	   of	   Ca2+-­‐dependent	  83	  
mechanisms.	  	  84	  
	  85	  
	   4	  
We	   hypothesised	   that	   calpain	   enzymes,	   Ca2+	   dependent	   non-­‐lysosomal	   proteases,	   might	   mediate	  86	  
sheath	   retraction.	   Calpains	   underpin	   many	   aspects	   of	   cellular	   breakdown,	   including	   the	   localised	  87	  
pruning	  of	  dendrites	  in	  Drosophila	  following	  large	  Ca2+	  transients14.	  To	  test	  whether	  calpain	  mediates	  88	  
myelin	  sheath	  retractions,	  we	  took	  chemical	  and	  genetic	  approaches.	  We	  first	  treated	  animals	  with	  the	  89	  
calpain	   inhibitor	   PD15060615	   from	   2-­‐4	   dpf,	   and	   assessed	   the	   morphology	   of	   individual	  90	  
oligodendrocytes	  with	  mbp:mCherry-­‐CAAX	  6.	  We	   found	  that	  PD150606	  treatment	   increased	  myelin	  91	  
sheath	  number	  per	  oligodendrocyte	  (Fig.	  2E,H)	  (Average	  sheath	  number	  per	  oligodendrocyte:	  DMSO	  92	  
14.4±3.2	  vs	  PD150606	  18.7±5.9).	  In	  order	  to	  whether	  calpain	  actually	  mediates	  retraction	  of	  sheaths,	  93	  
we	  carried	  out	  time-­‐lapse	  microscopy	  of	  PD150606-­‐treated	  animals.	  These	  studies	  revealed	  a	  lower	  94	  
rate	  of	  sheath	  retraction	  in	  calpain-­‐inhibited	  animals	  during	  the	  dynamic	  period	  of	  sheath	  stabilisation	  95	  
and	  retraction	  (Fig.	  2F,I	  and	  Supplementary	  movies	  5+6)	  (Sheath	  retraction	  per	  oligodendrocyte	  per	  96	  
hour,	  DMSO	  0.34±0.13	  vs	  PD150606	  0.24±0.13).	  To	  independently	  and	  cell	  autonomously	  test	  the	  role	  97	  
for	  calpain	   in	   regulating	  myelin	  sheath	  number,	  we	  expressed	  the	  endogenous	   inhibitor	  of	  calpain,	  98	  
calpastatin16,	  in	  myelinating	  oligodendrocytes	  (see	  Online	  Methods	  and	  Supplementary	  Fig.	  5).	  Analysis	  99	  
of	  oligodendrocyte	  morphology	  revealed	  that	  cell-­‐type	  specific	  disruption	  of	  calpain	  protease	  function	  100	  
increased	  the	  number	  of	  myelin	  sheaths	  compared	  to	  control	  (Fig.	  2G,J)	  (Average	  sheath	  number	  per	  101	  
cell	  mbp:meGFP	  15.8±6.4	  vs	  mbp:meGFP-­‐calpastatin	  20.5±5.8).	  102	  
Together,	  these	  data	  support	  our	  imaging-­‐driven	  hypothesis	  that	  calpain	  regulates	  retraction	  of	  myelin	  103	  
sheaths	  during	  the	  dynamic	  period	  of	  myelin	  sheath	  formation	  by	  individual	  oligodendrocytes.	  	  104	  
	  105	  
We	  next	  assessed	  how	  Ca2+	  transient	  activity	  might	  relate	  to	  myelin	  sheath	  growth.	  By	  comparing	  Ca2+	  106	  
activity	   and	   differential	   growth	   over	   time	   (Fig.	   3A,B),	   we	   found	   that	   the	   frequency	   of	   the	   lower	  107	  
amplitude	  shorter	  duration	  Ca2+	  transients	  observed	  in	  stabilised	  sheaths	  correlated	  positively	  with	  the	  108	  
speed	  of	  sheath	  elongation	  (Fig.	  3C,D).	  Interestingly,	  when	  we	  analysed	  how	  individual	  sheaths	  grew	  109	  
after	  each	  Ca2+	  transient,	  we	  observed	  positive	  elongation	  within	  the	  first	  2	  hours	  of	  the	  Ca2+	  transient	  110	  
(Fig.	  	  3E).	  We	  did	  not	  see	  any	  correlation	  between	  the	  average	  amplitude	  or	  duration	  of	  transients	  with	  111	  
the	  speed	  of	  growth	  (Supplementary	  Fig.	  6).	  These	  observations	  show	  the	  frequency	  of	  low	  amplitude	  112	  
short	  duration	  Ca2+	  transients	  in	  stabilised	  sheaths	  is	  predictive	  of	  their	  speed	  of	  elongation,	  suggesting	  113	  
that	  dynamic	  changes	  in	  myelin	  sheath	  Ca2+	  concentration	  regulate	  sheath	  growth.	  	  	  114	  
	  115	  
Our	  live	  imaging	  has	  revealed	  distinct	  signatures	  of	  localised	  Ca2+	  activity	  during	  CNS	  myelination.	  High-­‐116	  
amplitude	  long	  duration	  Ca2+	  transients	  precede	  localised	  retraction	  of	  sheaths,	  mediated	  by	  calpain,	  117	  
whereas	  the	  frequency	  of	  lower	  amplitude	  shorter	  duration	  transients	  in	  stabilised	  sheaths	  correlates	  118	  
	   5	  
positively	  with	  their	  speed	  of	  elongation	  (Summarised	  in	  Supplementary	  Fig.	  7).	  How	  could	  distinct	  Ca2+	  119	  
signatures	  lead	  to	  such	  different	  outcomes	  during	  myelination?	  With	  respect	  to	  sheath	  retraction,	  it	  is	  120	  
known	  that	  different	  isoforms	  of	  calpain	  have	  distinct	  sensitivities	  to	  Ca2+	  concentration,	  with	  some	  121	  
primed	  for	  activation	  by	   localised	  changes	   in	  Ca2+	  concentration17.	   It	   is	  possible	   that	   large	   localised	  122	  
increases	   in	   Ca2+	   concentration	   following	   individual	   high-­‐amplitude	   long-­‐duration	   transients	   could	  123	  
stimulate	   local	   protease	   activity	   that	   leads	   to	   sheath	   retraction,	   e.g.	   by	   localised	   degradation	   of	  124	  
cytoskeletal	  components.	  With	  respect	  to	  the	  speed	  of	  sheath	  elongation,	  it	  is	  now	  known	  that	  myelin	  125	  
sheath	  growth	  occurs	  is	  driven	  at	  inside	  of	  the	  myelin	  sheath3,	  at	  least	  in	  part,	  by	  iterative	  cycles	  of	  126	  
actin	  polymerisation	  and	  depolymerisation18.	  Given	  that	  actin	  polymerisation/depolymerisation	  can	  be	  127	  
regulated	  by	  Ca2+,	  it	  is	  possible	  that	  localised	  changes	  in	  Ca2+	  concentration	  could	  affect	  the	  speed	  of	  128	  
sheath	  growth	  via	  regulating	  the	  actin	  cytoskeleton.	  	  129	  
	  130	  
Many	  additional	  questions	  remain	  as	  to	  how	  localised	  Ca2+	  regulates	  myelination.	  Which	  signal(s)	  lead	  131	  
to	   the	  distinct	  changes	   in	  myelin	   sheath	  Ca2+	  during	   retraction,	   stabilisation	  and	  growth?	  Neuronal	  132	  
activity	   is	   one	   signal	   known	   to	   affect	   myelination5,8-­‐10,	   and	   many	   of	   its	   candidate	   mediators	   in	  133	  
oligodendrocytes	  converge	  on	  regulation	  of	   intracellular	  Ca2+	   19.	   Indeed,	  a	  complementary	  study	  to	  134	  
ours	  indicates	  that	  neuronal	  activity	  regulates	  about	  half	  of	  the	  Ca2+	  transients	  in	  myelin20.	  How	  Ca2+	  135	  
might	  affect	  ongoing	  sheath	  growth	  and	  remodelling	  throughout	   life,	  and	  during	  regeneration,	  also	  136	  
remain	  to	  be	  investigated.	  We	  anticipate	  that	  live	  Ca2+	  imaging-­‐focussed	  approaches	  will	  continue	  to	  137	  
elucidate	  the	  mechanisms	  underlying	  the	  dynamic	  regulation	  of	  myelination	  in	  the	  CNS.	  138	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Figure	  1.	  Live	  imaging	  reveals	  localised	  Ca2+	  activity	  in	  newly	  forming	  myelin	  sheaths	  186	  
A.	  Maximum	  intensity	  projection	  of	  a	  3D	  z-­‐stack	  of	  the	  first	  time-­‐point	  from	  a	  21	  minute-­‐long	  movie	  of	  187	  
a	  GCaMP6s	  expressing	  oligodendrocyte.	  Two	  areas	  of	  interest	  indicated,	  top	  corresponding	  to	  D	  and	  188	  
bottom	  to	  C.	  Scale	  bar=	  10µm.	  Fire	  LookUpTable.	  189	  
B.	  Maximum	  intensity	  projection	  of	  all	   time-­‐points	  of	  cell	  shown	  in	  A.	  Arrowheads	   indicate	  sheaths	  190	  
with	  increased	  fluorescence,	  reflecting	  Ca2+	  activity	  during	  the	  movie.	  Arrows	  point	  to	  sheaths	  with	  no	  191	  
increase.	  192	  
C,	  D,	  myelin	  sheaths	  demarcated	  within	  ROIs	  outlined	  in	  A,	  at	  indicated	  times.	  	  193	  
E.	  ∆F/F0	  over	  time.	  Arrowheads	  indicate	  sheaths	  shown	  in	  corresponding	  colours	  in	  B,	  C	  and	  D.	  	  194	  
F.	  Schematic	  of	  time-­‐lapse	  imaging	  experiment	  with	  interspersed	  imaging	  of	  cell	  morphology	  (yellow)	  195	  
and	  Ca2+	  (green).	  196	  
G.	  Sample	  images	  of	  myelin	  sheath	  morphology	  (under	  yellow	  bars)	  with	  intervening	  periods	  of	  Ca2+	  197	  
imaging	  (under	  green	  bar).	  Arrowhead	  points	  to	  Ca2+	  transient	  in	  sheath.	  Scale	  bar=5µm.	  	  198	  
H.	  Distribution	  of	  Ca2+	  transient	  frequencies	  of	  305	  sheaths,	  analysed	  in	  18	  animals.	  199	  
I.	  Distribution	  of	  average	  Ca2+	  transient	  amplitude	  per	  sheath	  (187	  sheaths	  from	  18	  animals).	  Graph	  200	  
shows	  median	  and	  1st	  and	  3rd	  quartiles.	  201	  
J.	  Distribution	  of	  average	  Ca2+	   transient	  duration	  per	   sheath	   (187	   sheaths	   from	  18	  animals).	  Graph	  202	  
shows	  median	  and	  1st	  and	  3rd	  quartiles.	  203	  
K.	  Correlation	  between	  amplitude	  and	  duration	  per	  individual	  Ca2+	  transient	  events	  (448	  events	  from	  204	  
187	  sheaths	  in	  18	  animals,	  Pearson’s	  Correlation	  Test,	  p=0.0006).	  	  205	  
	   	  206	  
	   8	  
	  207	  
Figure	  2.	  High-­‐amplitude	  long	  duration	  Ca2+	  transients	  precede	  calpain-­‐driven	  sheath	  retractions.	  208	  
A.	  Frames	  from	  a	  time-­‐lapse	  imaging	  experiment.	  The	  myelin	  sheath	  imaged	  in	  high-­‐resolution	  mode	  209	  
(0	  min)	  exhibits	  a	  Ca2+	  transient	  16	  minutes	  into	  a	  period	  of	  high-­‐speed	  GCaMP6s	  imaging	  (see	  also	  210	  
Supplementary	  Fig.	  3)	   subsequently	   retracts,	   first	  along	   the	   length	  of	   the	  axon	   (119	  min)	  and	   then	  211	  
entirely	  from	  the	  axon	  (205	  min,	  asterisk).	  Scale	  bar=	  5µm.	  	  212	  
B.	  Average	  amplitude	  of	  Ca2+	  transients	  in	  sheaths	  that	  are	  either	  stabilised	  or	  fully	  retracted	  (n=25	  213	  
retracted	  sheaths,	  12	  animals	  and	  n=162	  stabilised	  sheaths,	  18	  animals;	  Graph	  shows	  median	  and	  1st	  214	  
and	  3rd	  quartiles.	  Two-­‐tailed	  Mann-­‐Whitney	  test,	  p<0.0001.	  215	  
C.	  Average	  duration	  of	  Ca2+	   transients	   in	   sheaths	   shown	   in	  B.	  Graph	  shows	  median	  and	  1st	   and	  3rd	  216	  
quartiles.	  Two-­‐tailed	  Mann-­‐Whitney	  test,	  p=0.0048.	  217	  
D.	  Average	  amplitude	  and	  average	  duration	  of	  transient	  events	  in	  sheaths	  that	  are	  stabilised	  (green)	  218	  
or	  fully	  retracted	  (orange).	  	  219	  
E.	   mbp:mCherry-­‐CAAX	   expressing	   oligodendrocytes	   in	   control	   (top)	   and	   PD150606	   treated	   animal	  220	  
(bottom)	  at	  4	  dpf.	  Scale	  bar=	  10µm.	  	  Quantitation	  in	  2H.	  221	  
	   9	  
F.	  Frames	  from	  time-­‐lapse	  movies	  of	  oligodendrocytes	  during	  myelination	  in	  a	  DMSO	  treated	  (left)	  and	  222	  
PD150606	   treated	   (right)	   animal.	   Arrowheads	   point	   to	   sheaths	   that	   are	   retracted.	   See	   also	  223	  
Supplementary	  Movies	  5+6.	  Scale	  bar=	  10µm.	  Quantitation	  in	  2I.	  224	  
G.	  mbp:meGFP	  expressing	  oligodendrocytes	  (top)	  and	  mbp:meGFP-­‐calpastatin	  (bottom)	  at	  4	  dpf.	  Scale	  225	  
bar=	  10µm.	  Quantitation	  in	  2J.	  226	  
H.	  Myelin	  sheath	  number	  per	  oligodendrocyte	  in	  DMSO	  and	  PD150606	  treated	  animals	  (n=18	  OLs	  from	  227	  
18	  DMSO-­‐treated	  animals;	  n=	  33	  OLs	  from	  33	  PD150606-­‐treated	  animals;	  Graph	  shows	  mean	  and	  SD.	  228	  
Two-­‐tailed	  t-­‐test,	  p=0.006).	  229	  
I.	  Rate	  of	  myelin	  sheath	  retraction	  per	  hour	  in	  DMSO	  and	  PD150606	  treated	  animals	  as	  analysed	  by	  230	  
time-­‐lapse	  microscopy.	   (n=14	  OLs	   from	   14	  DMSO-­‐treated	   animals	   and	   34	  OLs	   from	   34	   PD150606-­‐231	  
treated	  animals.	  Graph	  shows	  mean	  and	  SD.	  Two-­‐tailed	  t-­‐test,	  p=0.013).	  	  232	  
J.	  Myelin	  sheath	  number	  per	  mbp:meGFP	  and	  mbp:meGFP-­‐calpastatin	  expressing	  oligodendrocytes	  at	  233	  
4	   dpf.	   (n=31	   OLs	   in	   22	   mbp:meGFP	   control	   animals,	   and	   n=29	   OLs	   in	   23	   mbp:meGFP-­‐calpastatin	  234	  
animals.	  Graph	  shows	  mean	  and	  SD.	  Two-­‐tailed	  t-­‐test,	  p=0.0043).	  235	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Figure	  3.	  Ca2+	  transient	  frequency	  correlates	  with	  sheath	  elongation	  239	  
A.	  Images	  of	  a	  GCaMP6s	  expressing	  oligodendrocyte	  in	  a	  Tg(sox10:mRFP)	  background	  allows	  analysis	  240	  
of	  the	  growth	  and	  Ca2+	  activity	  of	  individual	  isolated	  myelin	  sheaths,	  e.g.	  arrowheads	  over	  time.	  Top	  241	  
panels	  show	  initial	  time-­‐point	  and	  bottom	  the	  same	  cell	  at	  the	  end	  of	  the	  movie	  almost	  7	  hours	  later.	  242	  
Scale	  bar=	  5µm.	  	  243	  
B.	  Myelin	  sheaths	  indicated	  by	  arrowheads	  in	  A	  are	  outlined	  by	  ROIs	  and	  imaged	  over	  time.	  Note	  the	  244	  
Ca2+	  transient	  at	  0h	  10	  time-­‐point	  in	  the	  sheath	  in	  the	  left	  column	  subsequently	  elongates.	  245	  
C.	   Growth	   rate	   of	  myelin	   sheaths	   (µm/h)	   related	   to	   number	   of	   Ca2+	   transients	   per	   hour.	   (ANOVA	  246	  
p<0.0001,	  F=9.225.	  Two-­‐tailed	  unpaired	   t-­‐test,	  0	  vs	  >3	   transients/h	  p<0.0001,	  0	  vs	  2-­‐3	   transients/h	  247	  
p=0.0024,	  0	  vs	  1-­‐2	  transients/h	  p=0.0011,	  0	  vs	  <1	  transient/h	  p=0.0162,	  <1	  vs	  >3	  transients/h	  p=0.0006,	  248	  
1-­‐2	  vs	  >3	  transients/h	  p=0.0014,	  2-­‐3	  vs	  >3	  transients/h	  p=0.0376;	  0	  transient/h	  n=82	  sheaths	  from	  17	  249	  
animals,	  <1	   transient/h	  n=53	   from	  16	  animals,	  1-­‐2	   transients/h	  n=64	   sheaths	   from	  17	  animals,	  2-­‐3	  250	  
transients/h	  n=24	   sheaths	   from	  11	  animals,	   >3	   transients/h	  n=21	   sheaths	   from	  11	  animals).	  Graph	  251	  
indicates	  means	  and	  standard	  deviations.	  252	  
D.	  Scatterplot	  analysis	  of	  growth	  rate	  of	  myelin	  sheaths	  (µm/h)	  related	  to	  number	  of	  Ca2+	  transients	  253	  
per	  hour	  (Slope=	  0.108.	  Pearson’s	  Correlation	  Test,	  p<0.0001,	  n=244	  sheaths).	  254	  
E.	  Change	  in	  sheath	  length	  over	  time	  following	  324	  Ca2+	  transients,	  with	  the	  time	  of	  all	  transients	  set	  255	  
as	  time	  0	  (slope	  0.006,	  Linear	  Regression	  test,	  p<0.0001).	  	  256	  
	  257	  
	   	  258	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Online	  Methods	  259	  
Zebrafish	  husbandry	  260	  
All	   animal	   studies	   were	   carried	   out	   with	   approval	   from	   the	   UK	   Home	   Office	   and	   according	   to	   its	  261	  
regulations,	  under	  project	  licenses	  60/	  8436	  and	  70/8436.	  The	  project	  was	  approved	  by	  the	  University	  262	  
of	  Edinburgh	  Institutional	  Animal	  Care	  and	  Use	  Committee.	  We	  used	  zebrafish	  (Danio	  rerio)	  only,	  and	  263	  
the	   following	   transgenic	   lines	   in	   this	   study:	   tg(sox10(7.2):KalTA4GI)21,	   tg(UAS:mem-­‐GFP),	  264	  
tg(uas:GCaMP6s)13	  and	  tg(sox10:mRFP)22.	  All	  Ca2+	  imaging	  was	  carried	  out	  in	  the	  nacre	  background23,	  265	  
which	  lack	  melanocytes.	  266	  
Image	  acquisition	  267	  
We	   combined	   stable	   transgenic	   zebrafish	   Tg(sox10:KalTA4),	   which	   drives	   gene	   expression	   in	   the	  268	  
oligodendrocyte	   lineage,	   with	   Tg(uas:GCaMP6s)	   that	   expresses	   the	   genetically	   encoded	   calcium	  269	  
indicator	  GCaMP6s	  under	  the	  control	  of	  14X	  repetitive	  Upstream	  Activator	  Sequences	  (uas),	  the	  nacre	  270	  
homozygous	  mutant	   line	   that	   lacks	  melanocytes,	  and	  also	  Tg(sox10:mRFP)	  which	  drives	  membrane	  271	  
localised	   RFP	   expression	   in	   the	   myelinating	   oligodendrocyte	   lineage.	   The	   combination	   of	  272	  
Tg(sox10:KalTA4)	  and	  Tg(uas:GCaMP6s)	  leads	  to	  mosaic	  expression	  of	  GCaMP6s	  in	  isolated	  cells	  of	  the	  273	  
oligodendrocyte	  lineage	  in	  the	  CNS.	  274	  
Prior	  to	  imaging,	  larvae	  were	  screened	  for	  the	  expression	  of	  GCaMP6s	  in	  isolated	  oligodendrocytes	  in	  275	  
the	  dorsal	   spinal	   cord	  at	  3-­‐4	  days	  post	   fertilisation	   (dpf).	   Selected	   larvae	  were	  paralysed	  using	   the	  276	  
Neuromuscular	  Junction	  (NMJ)	  blocking	  nicotinic	  receptor	  antagonist	  pancuronium	  bromide	  (Sigma,	  277	  
P1918),	  which	  was	  dissolved	  in	  embryo	  medium	  (0.15-­‐0.3mg/ml).	  Larvae	  were	  then	  embedded	  in	  1.3%	  278	  
agarose	   for	   imaging.	   Imaging	  was	   carry	   out	   on	   an	   Olympus	   Revolution	   XDi	   spinning	   disk	   confocal	  279	  
microscope	  using	  a	  1.2	  NA	  60X	  water	  immersion	  objective,	  plus	  a	  camera	  zoom	  of	  2X,	  giving	  an	  X-­‐Y	  280	  
image	   area	   of	   117x117µm	   and	   acquisition	   at	   512x512	   pixels.	   Larvae	   were	   maintained	   at	   28°C	   in	  281	  
temperature	  controlled	  chamber	  (Okolab).	  Images	  were	  acquired	  using	  the	  iQ3	  software	  (Andor)	  and	  282	  
iXon	  EMCCD	  Ultra	  897	  camera.	  283	  
For	   initial	   2D	   characterisation	   of	   calcium	   transient	   kinetics,	   Tg(sox10:KalTA4,	   uas:GCaMP6s),	  284	  
Tg(sox10:mRFP)	  larva	  were	  time-­‐lapse	  imaged	  for	  periods	  of	  10-­‐30	  min	  with	  100ms	  exposure	  time,	  and	  285	  
150-­‐250ms	  intervals,	  reflecting	  imaging	  in	  one	  (GCaMP6s)	  or	  two	  (GCaMP6s	  and	  mRFP)	  channels,	  for	  286	  
a	  final	  rate	  of	  4-­‐6.66	  Hz	  (final	  rates	  also	  incorporate	  camera	  integration	  times).	  287	  
To	   investigate	   how	   Ca2+	   activity	   related	   to	   cell	   fate,	   Tg(sox10:KalTA4,	   uas:GCaMP6s,	   sox10:mRFP),	  288	  
nacre-­‐/-­‐	   larva	  were	   imaged	   every	   60-­‐120	  min	   as	   follows.	   First,	   one	   high-­‐resolution	   3D	   29µm	   deep	  289	  
(average±2µm)	   z-­‐stack	   of	   both	  RFP	   and	  GCaMP6s	   expression	  was	   acquired	   at	   100ms	  exposure,	   4x	  290	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averaging,	   and	   z-­‐intervals	  between	  optical	   slices	  of	  0.33µm.	   Immediately	   thereafter,	  3D	   time-­‐lapse	  291	  
images	  of	  GCaMP6s	  expression	   alone	  were	   acquired	  of	   the	   same	  29µm	   (±2µm)	   volume,	   at	   100ms	  292	  
exposure	  (no	  averaging),	  and	  z	  step	  of	  1.3µm.	  The	  time	  interval	  between	  consecutive	  z-­‐stacks	  in	  the	  293	  
time-­‐lapse	  was	  2.538s	  (±0.264s),	  including	  z-­‐positioning	  and	  camera	  integration	  times.	  Absolute	  values	  294	  
of	  imaging	  parameters	  were	  incorporated	  into	  analyses	  of	  all	  individual	  Ca2+	  transients	  and	  time-­‐lapse	  295	  
data.	  296	  
	  297	  
Image	  analysis	  298	  
2D	  time-­‐lapse	  imaging	  data	  were	  analysed	  using	  Fiji.	  To	  correct	  for	  sample	  drift	  throughout	  the	  movie	  299	  
we	  used	  the	  “Image	  stabilizer	  registration”	  Fiji	  plugin	  (Kang	  Li).	  Because	  of	  the	  very	  sparse	  labelling	  of	  300	  
individual	  GCaMP6s	  expressing	  oligodendrocytes	   it	   is	  possible	  to	   identify	  Ca2+	   transients	  by	  manual	  301	  
inspection	  of	  time-­‐lapse	  series.	  Regions	  of	  interest	  are	  then	  applied	  around	  all	  myelin	  sheaths	  and	  also	  302	  
in	   a	   separate	   area	   with	   no	   GCaMP6s	   expression,	   which	   represents	   background.	   Then	   fluorescent	  303	  
intensity	  measurements	  are	  extracted	  from	  both	  ROIs	  and	  imported	  into	  Excel.	  To	  measure	  ∆F/F0	  we	  304	  
apply	   the	   following	   formula:	   ∆F/F0=	   (F(t)-­‐F(0))/(F(0)-­‐F(background))	   where	   F(t)	   is	   the	   fluorescence	  305	  
intensity	  in	  the	  ROI	  in	  which	  the	  Ca2+	  transient	  was	  observed	  at	  time	  (t),	  F(0)	  the	  average	  fluorescence	  306	  
intensity	   of	   the	   first	   4	   frames	   of	   the	  movie	   in	   the	   same	   ROI	   and	   F(background)	   the	   fluorescence	  307	  
intensity	   of	   the	   background	   ROI	   at	   time	   (t).	   See	   Supplementary	   Figure	   1	   for	   overview.	   This	   ∆F/F0	  308	  
information	  and	  corresponding	   image	  acquisition	  parameters	  are	   imported	   into	  pClamp	  (Molecular	  309	  
Devices)	  for	  detailed	  analyses	  of	  the	  duration	  and	  amplitude	  of	  individual	  Ca2+	  transients.	  310	  
For	  3D	  time-­‐lapse	  imaging	  data,	  maximum	  intensity	  projections	  of	  the	  individual	  time-­‐points	  from	  3D	  311	  
time-­‐lapse	  data	  were	  made	  using	  Fiji	  and	  the	  image	  stabilizer	  Fiji	  plugin	  was	  again	  run	  to	  account	  for	  312	  
drift.	  In	  parallel	  3D	  datasets	  were	  registered	  using	  the	  “Descriptor-­‐based	  series	  registration	  (2d/3d+t)”	  313	  
Fiji	   plugin,	   after	   which	   maximum	   intensity	   projections	   are	   made	   and	   Ca2+	   transients	   identified	  314	  
manually.	  Ca2+	  transients	  were	  then	  identified	  manually.	  Only	  Ca2+	  transients	  identified	  following	  both	  315	  
modes	  of	  image	  processing	  were	  considered	  as	  valid.	  All	  myelin	  sheaths	  without	  overlapping	  structures	  316	  
in	  the	  X-­‐Y	  or	  Z	  planes	  were	  analysed.	  Regions	  of	  interest	  are	  then	  applied	  around	  all	  myelin	  sheaths	  317	  
and	  corresponding	  background,	  as	  above.	  In	  addition,	  the	  ROI	  with	  the	  candidate	  Ca2+	  transient	  was	  318	  
moved	  to	  an	  immediately	  adjacent	  region	  in	  order	  to	  rule	  out	  the	  possibility	  that	  any,	  very	  infrequent,	  319	  
general	   increase	   in	   background	   fluorescence	   in	   the	   region	   could	   identify	   a	   spurious	   transient.	   Key	  320	  
parameters	  for	  analysis	  of	  3D	  time-­‐lapse	  datasets	  were	  extracted	  from	  the	  iQ3	  metadata	  files	  using	  a	  321	  
custom-­‐written	  Fiji	  macro	  written	  by	  Dr.	  Bertrand	  Vernay,	  University	  of	  Edinburgh.	  These	  parameters	  322	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were	  then	  imported	  into	  Microsoft	  Excel	  for	  analysis.	  All	  Ca2+	  transients	  were	  identified	  by	  ∆F/F(0)	  as	  323	  
above	  and	  analysed	  using	  pClamp.	  	  324	  
	  325	  
To	  measure	  myelin	  sheath	  length,	  we	  used	  the	  3D	  high-­‐resolution	  single	  time	  z-­‐stack	  datasets	  acquired	  326	  
before	  each	  period	  of	  GCaMP6s	  time-­‐lapse	  imaging.	  The	  expression	  of	  GCaMP6s	  allowed	  identification	  327	  
of	   individual	  myelin	  sheaths	  and	   the	  membrane	   localised	  mRFP	   in	   the	  same	  sheaths	  allowed	  more	  328	  
accurate	  measurement	  of	  length.	  	  329	  
	  330	  
Calpain	  inhibitor	  treatment	  and	  analysis	  331	  
The	  calpain	  inhibitor	  PD150606	  (Tocris)	  was	  applied	  in	  solution	  from	  50µM	  -­‐75µM	  with	  1%	  DMSO	  to	  332	  
embryos	   from	   2-­‐4	   dpf	   and	   vehicle	   alone	   applied	   to	   controls.	   The	   morphology	   of	   myelinating	  333	  
oligodendrocytes	  was	  assessed	  as	  previously	  by	   imaging	   individual	  oligodendrocytes	  expressing	  the	  334	  
mbp:mCherry-­‐CAAX	   reporter6.	   Images	   of	   individual	  myelinating	   oligodendrocytes	  were	   taken	   on	   a	  335	  
Zeiss	   880	  with	  Airyscan,	   in	   animals	   immobilized	  using	   1.3%	   Low	  melting	  point	   agarose	  with	   0.03%	  336	  
Tricaine	   in	  embryo	  medium.	   Individual	  myelin	  sheaths	  were	   identified	   in	  3D	  z-­‐stacks	  and	  measured	  337	  
using	   Fiji.	   Time-­‐lapse	   analyses	   were	   carried	   out	   using	   tg(sox10(7.2):KalTA4GI),	   tg(UAS:mem-­‐GFP),	  338	  
animals,	  which	  were	  imaged	  on	  a	  Zeiss	  880	  Airyscan	  in	  Fast	  Mode	  and	  with	  a	  piezo	  z-­‐drive	  to	  allow	  339	  
rapid	  acquisition	  of	  confocal	   z-­‐stacks.	  Z-­‐stack	   images	  were	  collected	  every	  5	  minutes	   for	  a	  15	  hour	  340	  
period	  from	  81-­‐96	  hpf.	  341	  
	  342	  
Cell-­‐type	  specific	  expression	  of	  calpastatin	  in	  myelinating	  oligodendrocytes	  343	  
In	  order	  to	  disrupt	  calpain	  function	  in	  a	  cell	  type	  specific	  manner,	  we	  chose	  to	  express	  the	  endogenous	  344	  
inhibitor	   of	   calpain,	   calpastatin24,	   in	   myelinating	   oligodendrocytes.	   We	   first	   cloned	   zebrafish	  345	  
calpastatin.	  To	  do	  so,	  we	  extracted	  mRNA	  from	  whole	  zebrafish	  embryos	  at	  3	  and	  4	  dpf,	  generated	  346	  
cDNA	  and	  amplified	  calpastatin	  using	  the	  following	  primers	  castF:	  5’-­‐	  ATGGCGTACGCAATGTATTGG	  -­‐3’;	  347	  
castR:	  5’-­‐TTATCTTTTTCCAGCCTTTGTGG-­‐3’	  and	  high	  fidelity	  Phusion	  polymerase	  (Thermo	  Fisher).	  We	  348	  
cloned	   cast	   fragments	   into	   pCRTM-­‐Blunt	   II-­‐TOPOTM	   (Thermo	   Fisher)	   and	   Sanger	   sequenced	   clones	  349	  
(Source	  Bioscience).	  We	  subcloned	  multiple	  cast	  mRNA	  variants	  into	  pCS2+	  and	  generated	  synthetic	  350	  
mRNA,	  which	  we	  injected	  into	  animals	  at	  the	  one	  cell	  stage	  to	  identify	  full-­‐length	  version	  that	  lead	  to	  351	  
an	  increase	  in	  myelin	  sheath	  number	  per	  oligodendrocyte	  in	  the	  dorsal	  spinal	  cord	  (Supplementary	  Fig.	  352	  
5	  and	  data	  not	  shown).	  We	  next	  generated	  a	  p3E	  vector	  in	  which	  full	  length	  cast	  was	  flanked	  by	  p2A	  353	  
and	  a	  SV40	  polyA	  sequences.	  We	  then	  generated	  a	  pME	  vector	  with	  the	  Fyn	  myristoylation	  domain	  354	  
added	  to	  GFP,	  by	  amplifying	  GFP	  from	  pCS2+eGFP	  and	  adding	  the	  myristoylation	  sequence	  using	  the	  355	  
	   14	  
following	   primer	   meGFPF	   5’-­‐ATGGGCTGTGTGCAATGTAAGGATAAAGAAGCAACAAAACTGACG-­‐3.’	   To	  356	  
generate	   a	   construct	   for	   cell	   type	   specific	   expression	   of	   meGFP-­‐pA	   or	   meGFP-­‐2A-­‐cast-­‐pA	   we	  357	  
recombined	   the	   previously	   described	   p5E-­‐mbp	   plasmid	   containing	   zebrafish	   myelin	   basic	   protein	  358	  
regulatory	  sequence25,	  with	  the	  pME-­‐meGFP	  and	  p3E-­‐pA	  or	  with	  the	  pME-­‐meGFP	  and	  p3E-­‐2A-­‐cast-­‐pA.	  359	  
mbp:meGFP-­‐pA	  (5pg)	  or	  mbp:meGFP-­‐2A-­‐cast-­‐p2A	  (10pg)	  plasmids	  were	  injected	  into	  zebrafish	  at	  the	  360	  
1-­‐2	  cell	  stage	  together	  with	  25pg	  tol2	  mRNA26.	  Individual	  oligodendrocytes	  were	  imaged	  at	  4dpf	  using	  361	  
meGFP	  on	  a	  Zeiss	  880	  Airyscan	  confocal	  microscope	  in	  Fast	  Mode.	  	  	  362	  
	  363	  
Statistics	  and	  reproducibility	  364	  
All	  data	  are	  shown	  as	  mean	  ±	  standard	  deviation	  or	  median	  with	  1st	  and	  3rd	  quartiles	  as	  indicated.	  	  365	  
All	  the	  statistical	  tests	  were	  carry	  out	  using	  GraphPad	  (Prism	  6	  or	  7).	  Power	  calculations	  were	  calculated	  366	  
using	  Statemate	  2	  to	  determine	  for	  Ca2+	  imaging	  analyses,	  and	  investigations	  of	  the	  role	  of	  calpain	  367	  
signalling	  in	  myelination.	  All	  analyses	  had	  a	  power	  >80%.	  Randomisation	  of	  imaging	  and	  analyses	  was	  368	  
not	  carried	  out	  on	  animals	  whose	  myelin	  sheaths	  were	  Ca2+	  imaged,	  as	  all	  are	  wildtype.	  For	  chemical	  369	  
and	  genetic	  manipulations	  of	  calpain	  function,	  zebrafish	  embryos	  for	  both	  experimental	  and	  control	  370	  
conditions	   derived	   from	   the	   same	   clutch	   (per	   experiment).	   For	   time-­‐lapse	   analyses	   of	   chemical	  371	  
inhibitor	   treated	   animals,	   control	   and	   experimental	   animals	   were	   imaged	   separately	   for	   technical	  372	  
reasons.	  Embryos	  were	  grown	  up	  in	  the	  same	  incubator	  and	  the	  same	  conditions	  prior	  to	  analyses,	  all	  373	  
live	   imaging.	   During	   live	   imaging	   analyses,	   experimental	   and	   control	   animals	   were	   imaged	   in	   an	  374	  
alternating	   pattern	   (per	   experiment)	   to	   ensure	   no	   confounding	   effects	   of	   stage	   of	   development	  375	  
between	  groups.	  The	  analysis	  of	  all	  experimental	  findings	  were	  carried	  out	  blinded	  and	  image	  data	  was	  376	  
randomised	  using	  a	  custom-­‐made	  script.	  377	  
The	  data	  shown	  in	  Supplementary	  Figure	  1	  is	  representative	  of	  20	  myelin	  sheaths	  imaged	  in	  12	  animals	  378	  
over	  4	  separate	  experimental	  sessions.	  	  379	  
The	  data	  shown	  in	  Figure	  1A-­‐E	  and	  Supplementary	  Figure	  2	  are	  representative	  of	  40	  oligodendrocytes	  380	  
imaged	  in	  40	  animals	  over	  25	  separate	  occasions.	  381	  
The	  images	  analysed	  and	  data	  presented	  in	  Figures	  1G-­‐K,	  2A-­‐D	  and	  Figure	  3	  are	  representative	  of	  18	  382	  
cells	  imaged	  over	  9	  separate	  experimental	  sessions.	  383	  
The	  images	  analysed	  and	  data	  presented	  in	  Figure	  2E,H	  are	  representative	  of	  4	  experimental	  sessions.	  384	  
The	  images	  analysed	  and	  data	  presented	  in	  Figure	  2G,J	  are	  representative	  of	  4	  experimental	  sessions.	  385	  
	   15	  
The	  images	  analysed	  and	  data	  presented	  in	  Figure	  2F,I	  are	  representative	  of	  6	  experimental	  sessions.	  386	  
Data	   were	   tested	   for	   normality	   by	   the	   D'Agostino	   &	   Pearson	   omnibus	   normality	   test.	   Normal	  387	  
distributed	  data	  were	  tested	  as	  appropriate	  by	  two-­‐tailed	  student’s	  t-­‐test	  unpaired	  (equal	  variance	  was	  388	  
tested	  using	  the	  F	  test)	  or	  two-­‐tailed	  one-­‐way	  ANOVA	  (equal	  variance	  was	  tested	  using	  the	  Brown-­‐389	  
Forsythe	  test).	  Non-­‐normally	  distributed	  data	  were	  tested	  by	  a	  two-­‐tailed	  Mann-­‐Whitney	  tests.	  The	  390	  
Pearson’s	   correlation	   test	  was	   used	   to	   test	   the	   correlation	   in	   Fig.1J	   and	   Fig.	   3D.	   Linear	   regression	  391	  
analyses	  were	  used	  to	  test	  whether	  the	  slopes	  differed	  significantly	  from	  zero	  in	  Fig.	  3E.	  Throughout	  392	  
all	  analyses	  *	  p<0.05,	  **p<0.01,	  ***p<0.001,	  ****p<0.0001.	  393	  
Please	  see	  Life	  Sciences	  Reporting	  Summary	  for	  further	  details	  on	  experimental	  design.	  394	  
Data	  and	  code	  availability	  395	  
Transgenic	   constructs	   and	   transgenic	   zebrafish	   lines	  will	   be	   available	   upon	   request.	   The	   data	   that	  396	  
support	   the	   findings	   of	   this	   study	   are	   available	   from	   the	   corresponding	   author	   upon	   reasonable	  397	  
request.	  Custom	  written	  code	  for	  analyses	  of	  Ca2+	  imaging	  data	  are	  specific	  to	  the	  imaging	  platform,	  398	  
but	   details	   are	   available	   upon	   request.	   Custom	   written	   codes	   for	   blinding	   of	   image	   analyses	   are	  399	  
available	  upon	  request.	  	  400	  
	  401	  
Supplementary	  References	  (Online	  Methods)	  402	  
21.	   Almeida,	  R.G.	  &	  Lyons,	  D.A.	  Zebrafish	  12,	  377–386	  (2015).	  403	  
22.	   Kirby,	  B.B.	  et	  al.	  Nat	  Neurosci	  9,	  1506–1511	  (2006).	  404	  
23.	   White,	  R.M.	  et	  al.	  Cell	  Stem	  Cell	  2,	  183–189	  (2008).	  405	  
24.	   Kiss,	  R.,	  Kovács,	  D.,	  Tompa,	  P.	  &	  Perczel,	  A.	  Biochemistry	  47,	  6936–6945	  (2008).	  406	  
25.	   Almeida,	  R.G.,	  Czopka,	  T.,	  Ffrench-­‐Constant,	  C.	  &	  Lyons,	  D.A.	  Development	  138,	  4443–4450	  407	  
(2011).	  408	  
26.	   Kwan,	  K.M.	  et	  al.	  Dev.	  Dyn.	  236,	  3088–3099	  (2007).	  409	  
	  410	  
	  411	  
	  412	  
